Novavax Profit Margin 2006-2021 | NVAX
Current and historical gross margin, operating margin and net profit margin for Novavax (NVAX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Novavax net profit margin as of September 30, 2021 is -89.31%.
|Novavax Annual Profit Margins
|Novavax Quarterly Profit Margins
||Medical - Biomedical and Genetics
NOVAVAX INC is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on women's health and infectious diseases. Their technology platforms involve the use of proprietary, microscopic, organized, non-phospholipid structures as vehicles for the delivery of a wide variety of drugs and other therapeutic products, including certain hormones, anti-bacterial and anti-viral products and vaccine adjuvants.